NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Additionally, Nrf2 can regulate inflammatory responses and lipid metabolism by inhibiting NF-κB activation and reducing the release of inflammatory mediators, thus lowering hepatic inflammation and lipid accumulation, ultimately helping to block the progression of NAFLD/NASH (Bathish et al., 2022).